Zhengyu Li

760 citations
50 papers · 483 indexed · h-index 13
Topics
Ovarian cancer diagnosis and treatment (19 papers)Endometrial and Cervical Cancer Treatments (12 papers)PARP inhibition in cancer therapy (7 papers)

In The Last Decade

Zhengyu Li

47 papers receiving 479 citations

Peers

Zhengyu Li
Comparison fields: 5 of 75
  • Reproductive Medicine 191
  • Oncology 139
  • Obstetrics and Gynecology 127
  • Molecular Biology 92
  • Cancer Research 83
Replace Andrea Etrusco with:
Andrea Etrusco Italy
Mehmet Ali Vardar Türkiye
Jacob McGee Canada
Francesca Ciccarone Italy
Xufeng Wu China
Haldun Güner Türkiye
Karim ElSahwi United States
Theofano Orfanelli United States
Aine Clements United States
Jung Mi Byun South Korea
Zhengyu Li relative to Andrea Etrusco Italy Andrea Etrusco's profile →
Citations per field
00.5×4.0×
Andrea Etrusco · 1×
Citations per year

Countries citing papers authored by Zhengyu Li

Since Specialization
Citations

This map shows the geographic impact of Zhengyu Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhengyu Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhengyu Li more than expected).

Fields of papers citing papers by Zhengyu Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhengyu Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhengyu Li. The network helps show where Zhengyu Li may publish in the future.

Co-authorship network of co-authors of Zhengyu Li

This figure shows the co-authorship network connecting the top 25 collaborators of Zhengyu Li. A scholar is included among the top collaborators of Zhengyu Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhengyu Li. Zhengyu Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 6
2 1
3 4
4 1
5 6
6 12
7 2
8 7
9 9
10 36
11 5
12 14
13 11
14 3
15 9
16 1
17 9
18 1
19 8
20 11

About Zhengyu Li

Zhengyu Li is a scholar working on Reproductive Medicine, Obstetrics and Gynecology and Oncology, having authored 50 papers that have together received 483 indexed citations. Recurring topics across this work include Ovarian cancer diagnosis and treatment (19 papers), Endometrial and Cervical Cancer Treatments (12 papers) and PARP inhibition in cancer therapy (7 papers). The work is most often cited by research in Reproductive Medicine (191 citations), Obstetrics and Gynecology (127 citations) and Transplantation (17 citations). Zhengyu Li has collaborated with scholars based in China, United States and Denmark. Frequent co-authors include Dan Nie, Yue Huang, Wenjiao Min, Xia Zhao, Caixia Jiang, Jinhai Gou, Qin Xu, Yuquan Wei, Canhua Huang and Xiaoling Pan. Their work appears in journals such as International Journal of Cancer, Journal of Affective Disorders and BJOG An International Journal of Obstetrics & Gynaecology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026